ALAB vs TECH · P/E 78, rev $396.3M vs P/E 65, rev $1.22B
Astera Labs, Inc. Common Stock (ALAB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Astera Labs, Inc. Common Stock (ALAB) is a semiconductors company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ALAB revenue for 2024-12-31 was $396.3M. Net income was -$83.4M. Revenue was up 242.2% from 2023-12-31 to 2024-12-31. ALAB currently screens at market cap $16.84B and trailing P/E 78.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ALAB currently screens at market cap $16.84B and trailing P/E 78.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ALAB and TECH stock pages for the full models.
Not investment advice.